178 related articles for article (PubMed ID: 38638892)
1. Efficacy of antithrombin administration for patients with sepsis: A systematic review, meta-analysis, and meta-regression.
Tsuchida T; Makino Y; Wada T; Ushio N; Totoki T; Fujie N; Yasuo S; Matsuoka T; Koami H; Yamakawa K; Iba T
Acute Med Surg; 2024; 11(1):e950. PubMed ID: 38638892
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. A systematic review of antithrombin concentrate use in patients with disseminated intravascular coagulation of severe sepsis.
Wiedermann CJ; Kaneider NC
Blood Coagul Fibrinolysis; 2006 Oct; 17(7):521-6. PubMed ID: 16988545
[TBL] [Abstract][Full Text] [Related]
4. Antithrombin concentrate use in disseminated intravascular coagulation of sepsis: meta-analyses revisited.
Wiedermann CJ
J Thromb Haemost; 2018 Mar; 16(3):455-457. PubMed ID: 29316235
[TBL] [Abstract][Full Text] [Related]
5. The anticoagulant treatment for sepsis induced disseminated intravascular coagulation; network meta-analysis.
Yatabe T; Inoue S; Sakamoto S; Sumi Y; Nishida O; Hayashida K; Hara Y; Fukuda T; Matsushima A; Matsuda A; Yasuda H; Yamashita K; Egi M
Thromb Res; 2018 Nov; 171():136-142. PubMed ID: 30312798
[TBL] [Abstract][Full Text] [Related]
6. Effects of combination therapy of antithrombin and thrombomodulin for sepsis-associated disseminated intravascular coagulation: a systematic review and meta-analysis.
Totoki T; Makino Y; Yamakawa K; Koami H; Wada T; Ito T; Iba T
Thromb J; 2024 Jan; 22(1):10. PubMed ID: 38225597
[TBL] [Abstract][Full Text] [Related]
7. Antithrombin concentrate use in sepsis-associated disseminated intravascular coagulation: re-evaluation of a 'pendulum effect' drug using a nationwide database.
Tagami T
J Thromb Haemost; 2018 Mar; 16(3):458-461. PubMed ID: 29316251
[TBL] [Abstract][Full Text] [Related]
8. Recombinant human soluble thrombomodulin in severe sepsis: a systematic review and meta-analysis.
Yamakawa K; Aihara M; Ogura H; Yuhara H; Hamasaki T; Shimazu T
J Thromb Haemost; 2015 Apr; 13(4):508-19. PubMed ID: 25581687
[TBL] [Abstract][Full Text] [Related]
9. Antithrombin and mortality in severe pneumonia patients with sepsis-associated disseminated intravascular coagulation: an observational nationwide study.
Tagami T; Matsui H; Horiguchi H; Fushimi K; Yasunaga H
J Thromb Haemost; 2014 Sep; 12(9):1470-9. PubMed ID: 24943516
[TBL] [Abstract][Full Text] [Related]
10. Management of disseminated intravascular coagulation: current insights on antithrombin and thrombomodulin treatments.
Hayakawa M
Open Access Emerg Med; 2018; 10():25-29. PubMed ID: 29343993
[TBL] [Abstract][Full Text] [Related]
11. Effects of combination therapy using antithrombin and thrombomodulin for sepsis-associated disseminated intravascular coagulation.
Iba T; Hagiwara A; Saitoh D; Anan H; Ueki Y; Sato K; Gando S
Ann Intensive Care; 2017 Nov; 7(1):110. PubMed ID: 29098447
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and bleeding risk of antithrombin supplementation in septic disseminated intravascular coagulation: a secondary survey.
Iba T; Saitoh D; Wada H; Asakura H
Crit Care; 2014 Sep; 18(5):497. PubMed ID: 25220851
[TBL] [Abstract][Full Text] [Related]
13. Antithrombin III for critically ill patients.
Allingstrup M; Wetterslev J; Ravn FB; Møller AM; Afshari A
Cochrane Database Syst Rev; 2016 Feb; 2(2):CD005370. PubMed ID: 26858174
[TBL] [Abstract][Full Text] [Related]
14. A randomized, controlled, multicenter trial of the effects of antithrombin on disseminated intravascular coagulation in patients with sepsis.
Gando S; Saitoh D; Ishikura H; Ueyama M; Otomo Y; Oda S; Kushimoto S; Tanjoh K; Mayumi T; Ikeda T; Iba T; Eguchi Y; Okamoto K; Ogura H; Koseki K; Sakamoto Y; Takayama Y; Shirai K; Takasu O; Inoue Y; Mashiko K; Tsubota T; Endo S;
Crit Care; 2013 Dec; 17(6):R297. PubMed ID: 24342495
[TBL] [Abstract][Full Text] [Related]
15. Antithrombin supplementation and risk of bleeding in patients with sepsis-associated disseminated intravascular coagulation.
Iba T; Gando S; Saitoh D; Wada H; Di Nisio M; Thachil J
Thromb Res; 2016 Sep; 145():46-50. PubMed ID: 27479532
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of anticoagulant therapy in three specific populations with sepsis: a meta-analysis of randomized controlled trials.
Umemura Y; Yamakawa K; Ogura H; Yuhara H; Fujimi S
J Thromb Haemost; 2016 Mar; 14(3):518-30. PubMed ID: 26670422
[TBL] [Abstract][Full Text] [Related]
17. Studies on therapeutic effects and pathological features of an antithrombin preparation in septic disseminated intravascular coagulation patients.
Sakamoto Y; Inoue S; Iwamura T; Yamashita T; Nakashima A; Nishimura Y; Koami H; Imahase H; Goto A; Yamada KC; Mashiko K; Yokota H
Yonsei Med J; 2013 May; 54(3):686-9. PubMed ID: 23549815
[TBL] [Abstract][Full Text] [Related]
18. Anticoagulant therapies against sepsis-induced disseminated intravascular coagulation.
Umemura Y; Nishida T; Yamakawa K; Ogura H; Oda J; Fujimi S
Acute Med Surg; 2023; 10(1):e884. PubMed ID: 37670904
[TBL] [Abstract][Full Text] [Related]
19. Supplemental dose of antithrombin use in disseminated intravascular coagulation patients after abdominal sepsis.
Tagami T; Matsui H; Fushimi K; Yasunaga H
Thromb Haemost; 2015 Aug; 114(3):537-45. PubMed ID: 25948492
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
